BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01152788-completion@plaintrial.com
DTSTAMP:20261111T004550Z
DTSTART;VALUE=DATE:20150213
SUMMARY:Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in 
 Patients With Metastatic or Recurrent Melanoma — estimated completion da
 te
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01152788
URL:https://plaintrial.com/trial/NCT01152788
END:VEVENT
END:VCALENDAR